NAOV — NanoVibronix Income Statement
0.000.00%
Last trade - 00:00
- $1.92m
- -$0.25m
- $2.28m
- 34
- 66
- 27
- 38
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.53 | 0.623 | 1.7 | 0.752 | 2.28 |
Cost of Revenue | |||||
Gross Profit | 0.281 | 0.214 | 0.77 | 0.167 | 1.54 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 5.97 | 5.3 | 7.38 | 5.76 | 5.72 |
Operating Profit | -5.44 | -4.68 | -5.68 | -5.01 | -3.44 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.81 | -4.31 | -14.3 | -5.41 | -3.68 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.79 | -4.33 | -14.3 | -5.45 | -3.71 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.79 | -4.33 | -14.3 | -5.45 | -3.71 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.79 | -4.33 | -14.3 | -5.45 | -3.71 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -26.7 | -8.45 | -11.4 | -3.84 | -2.12 |